Brief: Regenxbio - Completes Dosing In Rgx-202 Confirmatory Study
24/06/2026 12:27
BRIEF-Regenxbio - Completes Dosing In Rgx-202 Confirmatory Study June 24 (Reuters) - Regenxbio Inc RGNX.O:
REGENXBIO - COMPLETES DOSING IN RGX-202 CONFIRMATORY STUDY
REGENXBIO - ON TRACK TO INITIATE BLA FOR RGX-202 IN Q3 2026
Source text: ID:nPnbKjDPRa
Further company coverage: RGNX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on REGENXBIO
See all newsBrief: Regenxbio says Sarepta To Pay $39 Million To Regenxbio Within 10 Days Of Effective Date
Regenxbio climbs as new director buys nearly $1 million of stock
Brief: Regenxbio Strengthens Board Of Directors With Appointment Of Greg Ciongoli
U.S. STOCKS ON THE MOVE-Strategy, Ecovyst, Azenta
U.S. STOCKS ON THE MOVE-Azenta, Qiagen NV, Capricor Therapeutics